nach oben

Urolithiasis

Erschienen in:

01.12.2023 | Research

Comparative analysis of re-entry malecot and nelaton catheters after standard percutaneous nephrolithotomy in adult patients: a cross-sectional study

verfasst von: Remzi Salar, Kemal Gümüş, Tuncer Bahçeci, Akif Erbin

Erschienen in: Urolithiasis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Drainage catheters are used almost routinely to provide urinary drainage, prevent extravasation of urine, and create tamponade against bleeding after percutaneous nephrolithotomy (PNL). In the literature, there is no standardized approach to determining which type of catheter is superior. In this context, we aimed to comparatively analyze two different types of catheters (re-entry malecot catheter and nelaton catheter) in terms of success and complications, which we use for drainage after a PNL operation and which have very different costs. Patients who underwent PNL for kidney stones between January 2018 and October 2022 were included in the study. The data of a total of 148 patients who had a 16-F reentry malecot nephrostomy catheter or a 16-F nelaton catheter were analyzed. In addition to the demographic characteristics of the patients, stone characteristics, operative data, hospitalization time, analgesia requirement, hemoglobin exchange, amount of blood transfusion, and postoperative data (success and complications) were comparatively evaluated. The current unit price for a reentry malecot and a nelaton catheter is 4.7 United States dollars (USD) and 0.11 USD, respectively. There were a total of 148 patients in the study, 63 of whom were nelaton catheters and 85 were reentry malecots, and the mean age was 39.95 ± 13.28 years. There was no statistically significant difference between preoperative stone sizes and residual stone rates according to the groups. In addition, there was no statistically significant difference between the groups in terms of access site and stone localization. There was no significant difference between the groups in terms of complication rates according to the Clavien–Dindo classification, Hb levels, blood transfusion rates, operation times, or hospitalization times. In conclusion, if a second procedure is planned, a reentry malecot catheter may be preferred. Apart from this situation, nelaton catheters should be preferred because they are similar to reentry catheters in terms of effectiveness, and side effects and are more economical than reentry catheters in terms of cost.

Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol 35:1301–1320. https://doi.org/10.1007/s00345-017-2008-6CrossRefPubMed

Muslumanoglu AY, Binbay M, Yuruk E, Akman T, Tepeler A, Esen T et al (2011) Updated epidemiologic study of urolithiasis in Turkey. I: changing characteristics of urolithiasis. Urol Res 39(4):309–314. https://doi.org/10.1007/s00240-010-0346-6CrossRefPubMed

Urolithiasis Guidelines (2022) European Association of Urology. https://uroweb.org/guidelines/urolithiasis.

Bolat MS, Akdeniz E (2017) Can CROES nephrolithometric nomogram predict postoperative outcomes of percutaneous nephrolithotomy? New J Urol 12:25–31

Lee JK, Kim BS, Park YK (2013) Predictive factors for bleeding during percutaneous nephrolithotomy. Korean J Urol 54(7):448–453. https://doi.org/10.4111/kju.2013.54.7.448CrossRefPubMedPubMedCentral

Akman T, Binbay M, Sari E, Yuruk E, Tepeler A, Akcay M et al (2011) Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience. J Endourol 25(2):327–333. https://doi.org/10.1089/end.2010.0302CrossRefPubMed

Paul EM, Marcovich R, Lee BR, Smith AD (2003) Choosing the ideal nephrostomy tube. BJU Int 92:672–677. https://doi.org/10.1046/j.1464-410x.2003.04454.xCrossRefPubMed

Gupta M, Bellman GC, Smith AD (1997) Massive hemorrhage from renal vein injury during percutaneous renal surgery: endourological management. J Urol 157:795–797. https://doi.org/10.1016/S0022-5347(01)65042-0CrossRefPubMed

Jamil S, Ather MH (2020) The impact of post PNL tube type on blood loss and postoperative pain. Pak J Med Sci 36(3):402–406. https://doi.org/10.1266/pjms.36.3.1558CrossRefPubMedPubMedCentral

10.

Kim SC, Tinmouth WW, Kuo RL, Paterson RF, Lingeman JE (2005) Using and choosing a nephrostomy tube after percutaneous nephrolithotomy for large or complex stone disease: a treatment strategy. J Endourol 19(3):348–352. https://doi.org/10.1089/end.2005.19.348CrossRefPubMed

11.

De la Rosette JJ, Opondo D, Daels FP, Giusti G, Serrano A, Kandasami SV et al (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62(2):246–255. https://doi.org/10.1016/j.eururo.2012.03.055CrossRefPubMed

12.

Srinivasan AK, Herati A, Okeke Z, Smith AD (2009) Renal drainage after percutaneous nephrolithotomy. J Endourol 23(10):1743–1749. https://doi.org/10.1089/end.2009.1545CrossRefPubMed

13.

Chang CH, Wang CJ, Huang SW (2011) Totally tubeless percutaneous nephrolithotomy: a prospective randomized controlled study. Urol Res 39:459–465. https://doi.org/10.1007/s00240-011-0363-0CrossRefPubMed

14.

Gonen M, Ozturk B, Ozkardes H (2009) Double-j stenting compared with one night externalized ureteral catheter placement in tubeless percutaneous nephrolithotomy. J Endourol 23:27–31. https://doi.org/10.1089/end.2008.0382CrossRefPubMed

15.

Choi M, Brusky J, Weaver J, Amantia M, Bellman GC (2006) Randomized trial comparing modified tubeless percutaneous nephrolithotomy with tailed stent with percutaneous nephrostomy with small-bore tube. J Endourol 20:766–770. https://doi.org/10.1089/end.2006.20.766CrossRefPubMed

16.

Candela J, Davidoff R, Gerspach J, Bellman GC (1997) “Tubeless” percutaneous surgery: a new advance in the technique of percutaneous renal surgery. Tech Urol 3:6–11PubMed

17.

Jiang H, Huang D, Yao S, Liu S (2017) Improving drainage after percutaneous nephrolithotomy based on health-related quality of life: a prospective randomized study. J Endourol 31(11):1131–1138. https://doi.org/10.1089/end.2017.0444CrossRefPubMed

18.

Kumar S, Singh S, Singh P, Singh SK (2016) Day care PNL using ‘Santosh-PGI hemostatic seal’ versus standard PNL: a randomized controlled study. Cent Eur J Urol 69(2):190–197. https://doi.org/10.5173/ceju.2016.792CrossRef

19.

Lightfoot M, Ng C, Engebretsen S, Wallner C, Huang G, Li R et al (2014) Analgesic use and complications following upper pole access for percutaneous nephrolithotomy. J Endourol 28(8):909–914. https://doi.org/10.1089/end.2014.0035CrossRefPubMed

20.

Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906. https://doi.org/10.1016/j.eururo.2006.10.020CrossRefPubMed

21.

Oguz U, Resorlu B, Bayindir M, Sahin T, Bozkurt OF, Unsal A (2013) Emergent intervention criterias for controlling sever bleeding after percutaneous nephrolithotomy. ISRN Urol. https://doi.org/10.1155/2013/760272CrossRefPubMedPubMedCentral

22.

Taylor E, Miller J, Chi T, Stoller ML (2012) Complications associated with percutaneous nephrolithotomy. Transl Androl Urol 1:223–228. https://doi.org/10.3978/j.issn.2223-4683.2012.12.01CrossRefPubMedPubMedCentral

23.

Unsal A, Resorlu B, Atmaca AF, Diri A, Goktug HN, Can CE et al (2012) Prediction of morbidity and mortality after percutaneous nephrolithotomy by using the charlson comorbidity index. Urology 79(1):55–60. https://doi.org/10.1016/j.urology.2011.06.038CrossRefPubMed

24.

Lopes T, Sangam K, Alken P, Barroilhet BS, Saussine C, Shi L et al (2011) The clinical research office of the endourological society percutaneous nephrolithotomy global study: tract dilation comparisons in 5537 patients. J Endourol 25(5):755–762. https://doi.org/10.1089/end.2010.0488CrossRefPubMed

25.

Stoller ML, Wolf JS Jr, St Lezin MA (1994) Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy. J Urol 152:1977–1981. https://doi.org/10.1016/s0022-5347(17)32283-8CrossRefPubMed

26.

Seitz C, Desai M, Häcker A, Hakenberg OW, Liatsikos E, Nagele U et al (2012) Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol 61(1):146–158. https://doi.org/10.1016/j.eururo.2011.09.016CrossRefPubMed

27.

De la Rosette J, Assimos D, Desai M, Gutierrez J, Lingeman J, Scarpa R et al (2011) The clinical research office of the endourological society percutaneous nephrolithotomy global study: indications, complications, and outcomes in 5803 patients. J Endourol 25(1):11–17. https://doi.org/10.1089/end.2010.0424CrossRefPubMed

28.

Tefekli A, Karadag MA, Tepeler K, Sari E, Berberoglu Y, Baykal M et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53(1):184–190. https://doi.org/10.1016/j.eururo.2007.06.049CrossRefPubMed

29.

Gök A, Çift A, Yücel MÖ, Atar M, Çimen S, Öztürk U et al (2018) Evaluation of complications of percutaneous nephrolithotomy operations performed at our clinic using modified Clavien classification system. Bozok Med J 8(1):5–10

30.

Dunn JC, Lanzi J, Kusnezov N, Bader J, Waterman BR, Belmont PJ (2015) Predictors of length of stay after elective total shoulder arthroplasty in the United States. J Shoulder Elbow Surg 24(5):754–759. https://doi.org/10.1016/j.jse.2014.11.042CrossRefPubMed

31.

Kumar S, Karthikeyan VS, Mallya A, Keshavamurthy R (2018) Outcomes of second-look percutaneous nephrolithotomy in renal calculi-a single centre experience. Turk J Urol 44(5):406–410. https://doi.org/10.5152/tud.2018.76299CrossRefPubMedPubMedCentral

Titel: Comparative analysis of re-entry malecot and nelaton catheters after standard percutaneous nephrolithotomy in adult patients: a cross-sectional study
verfasst von: Remzi Salar
Kemal Gümüş
Tuncer Bahçeci
Akif Erbin
Publikationsdatum: 01.12.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 1/2023
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-023-01475-x

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Population genetics analysis of SLC3A1 and SLC7A9 revealed the etiology of cystine stone may be more than what our current genetic knowledge can explain

A retrospective study using machine learning to develop predictive model to identify urinary infection stones in vivo

The altered composition of gut microbiota and biochemical features as well as dietary patterns in a southern Chinese population with recurrent renal calcium oxalate stones

The microbiome of kidney stones and urine of patients with nephrolithiasis